Drug Profile
RII retinamide - Chinese Academy of Medical Sciences
Latest Information Update: 08 Aug 2007
Price :
$50
*
At a glance
- Originator Chinese Academy of Medical Sciences
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Preleukaemia
Most Recent Events
- 01 Feb 2000 Suspended-II for Preleukaemia in USA (PO)
- 01 Feb 2000 Suspended-Registered for Preleukaemia in China (Topical)
- 01 Feb 2000 Suspended-Registered for Preleukaemia in China (PO)